LEADER 03940nam 2201033z- 450 001 9910595076103321 005 20231214133349.0 035 $a(CKB)5680000000080765 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/92063 035 $a(EXLCZ)995680000000080765 100 $a20202209d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNovel Biomarkers of Gastrointestinal Cancer 210 $aBasel$cMDPI Books$d2022 215 $a1 electronic resource (248 p.) 311 $a3-0365-4932-3 311 $a3-0365-4931-5 330 $aGastrointestinal (GI) cancer is a major cause of morbidity and mortality in the world. Since early diagnosis and optimal treatment selection are crucial to improving the prognosis of these diseases, the discovery of useful biomarkers has the potential to greatly reduce their burden. Recent technical and mechanical developments have allowed for the detection of tiny differences in various factors modified in physical conditions, which could contribute to the discovery of novel biomarkers for some diseases.In this Special Issue, we aim to focus on novel biomarkers for GI cancers, including esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer and biliary cancer. In addition, any samples (tissue, blood, urine and feces) are useful as biomarker sources, although body-fluid-based biomarkers are promising as diagnostic biomarkers due to their noninvasiveness. This Special Issue aims to collect novel insights clarifying the current situation and future perspective in this field. 606 $aMedicine$2bicssc 606 $aOncology$2bicssc 610 $acolorectal cancer 610 $aadvanced adenoma 610 $ascreening 610 $astool 610 $amRNA 610 $acancer screening 610 $acirrhosis 610 $aAFP 610 $amachine learning 610 $aMALDI-TOF 610 $aproteomics 610 $aCXCR4 610 $aprognosis 610 $aoverall survival 610 $arectal cancer 610 $aneoadjuvant chemoradiation 610 $amouse model 610 $abiomarkers 610 $aurokinase plasminogen activator (uPA) 610 $aurokinase plasminogen activator receptor (uPAR) 610 $aplasminogen activator inhibitor type 1 (PAI-1) 610 $acirculating tumour cell (CTC) 610 $agastric cancer 610 $aoesophageal cancer 610 $aserine proteases 610 $atumour microenvironment 610 $aserpins 610 $abiomarker 610 $achemoresistance 610 $aliquid biopsy 610 $amicroRNA 610 $along non-coding RNA 610 $acolorectal neoplasms 610 $acancer screening tests 610 $aearly detection of cancer 610 $aprecision medicine 610 $aunfolded protein 610 $ahepatocellular cancer 610 $aGSVA 610 $aunfolded protein score 610 $aepigenetic regulation genes 610 $asomatic mutations 610 $amolecular genetic markers 610 $aextracellular vesicles 610 $amicrobiome 610 $a16S rRNA amplicon 610 $ametagenomics 610 $aliver fibrosis 610 $ahepatocellular carcinoma 610 $arecurrence 610 $aSHG/TPEF microscopy 610 $aartificial intelligence 610 $aadvanced gastric cancer 610 $atargeted therapy 610 $aurinary miRNA 610 $amiR-129-1-3p 610 $amiR-566 615 7$aMedicine 615 7$aOncology 700 $aShimura$b Takaya$4edt$01329046 702 $aShimura$b Takaya$4oth 906 $aBOOK 912 $a9910595076103321 996 $aNovel Biomarkers of Gastrointestinal Cancer$93039266 997 $aUNINA LEADER 03018 am 2200601 n 450 001 9910495829703321 005 20240104030455.0 010 $a2-35671-482-0 024 7 $a10.4000/books.pressesmines.3463 035 $a(CKB)3710000001633298 035 $a(FrMaCLE)OB-pressesmines-3463 035 $a(PPN)204524393 035 $a(EXLCZ)993710000001633298 100 $a20170828j|||||||| ||| 0 101 0 $aeng 135 $auu||||||m|||| 200 00$aCapitalization$eA Cultural Guide$fCollectif CSI 210 $aParis$cPresses des Mines$d2017 215 $a1 online resource (168 p.) 311 $a2-35671-422-7 330 $aWhat does it mean to turn something into capital? What does considering things as assets entail? What does the prevalence of an investor?s viewpoint require? What is this culture of valuation that asks that we capitalize on everything? How can we make sense of the traits, necessities and upshots of this pervasive cultural condition?This book takes the reader to an ethnographic stroll down the trail of capitalization. Start-up companies, research centers, consulting firms, state enterprises, investment banks, public administrations: the territory can certainly prove strange and disorienting at first sight, with its blurred boundaries between private appropriation and public interest, economic sanity and moral breakdown, the literal and the metaphorical, the practical and the ideological. The traveler certainly requires a resolutely pragmatist attitude, and a taste for the meanders of signification. But in all the sites in which we set foot in this inquiry we recognize a recurring semiotic complex: a scenario of valuation in which things signify by virtue of their capacity to become assets in the eye of an imagined investor.A ground-breaking anthropological investigation on the culture of contemporary capitalism, this work directs attention to the largely unexplored problem of capitalization and offers a critical resource for current debates on neoliberalism and financialization. 606 $aSocial Sciences, Interdisciplinary 606 $aEconomics (General) 606 $acapitalisme 606 $aanthropologie économique 606 $asociologie 606 $asociologie économique 606 $amarché 606 $afinance 606 $aanthropology 606 $aeconomics 606 $acapitalism 606 $atrade 606 $asociology 615 4$aSocial Sciences, Interdisciplinary 615 4$aEconomics (General) 615 4$acapitalisme 615 4$aanthropologie économique 615 4$asociologie 615 4$asociologie économique 615 4$amarché 615 4$afinance 615 4$aanthropology 615 4$aeconomics 615 4$acapitalism 615 4$atrade 615 4$asociology 700 $aCollectif CSI$01457908 801 0$bFR-FrMaCLE 906 $aBOOK 912 $a9910495829703321 996 $aCapitalization$93658133 997 $aUNINA